Noritoshi Nagaya

Summary

Affiliation: National Cardiovascular Center
Country: Japan

Publications

  1. ncbi Therapeutic potential of ghrelin in the treatment of heart failure
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan
    Drugs 66:439-48. 2006
  2. ncbi Adrenomedullin: angiogenesis and gene therapy
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Physiol Regul Integr Comp Physiol 288:R1432-7. 2005
  3. ncbi Treatment of cachexia with ghrelin in patients with COPD
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Chest 128:1187-93. 2005
  4. ncbi Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka 565 8565, Japan
    Circulation 112:1128-35. 2005
  5. ncbi Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis
    Noritoshi Nagaya
    Dept of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Physiol Heart Circ Physiol 287:H2670-6. 2004
  6. ncbi Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Circulation 110:3674-9. 2004
  7. ncbi Adrenomedullin enhances therapeutic potency of bone marrow transplantation for myocardial infarction in rats
    Takafumi Fujii
    Department of Cardiac Physiology, National Cardiovascular Center, Suita, Osaka, Japan
    Am J Physiol Heart Circ Physiol 288:H1444-50. 2005
  8. ncbi Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia
    Takashi Iwase
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    Circulation 111:356-62. 2005
  9. ncbi Infusion of adrenomedullin improves acute myocarditis via attenuation of myocardial inflammation and edema
    Bobby Yanagawa
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan
    Cardiovasc Res 76:110-8. 2007
  10. ncbi A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension
    Masaharu Kataoka
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Respir Crit Care Med 172:1575-80. 2005

Detail Information

Publications85

  1. ncbi Therapeutic potential of ghrelin in the treatment of heart failure
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan
    Drugs 66:439-48. 2006
    ..Thus, administration of ghrelin may be a new therapeutic strategy for the treatment of severe CHF...
  2. ncbi Adrenomedullin: angiogenesis and gene therapy
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Physiol Regul Integr Comp Physiol 288:R1432-7. 2005
    ..These results suggest that in vivo and in vitro transfer of AM gene using gelatin may be applicable for intractable cardiovascular disease...
  3. ncbi Treatment of cachexia with ghrelin in patients with COPD
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Chest 128:1187-93. 2005
    ..We investigated whether ghrelin improves cachexia and functional capacity in patients with COPD...
  4. ncbi Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka 565 8565, Japan
    Circulation 112:1128-35. 2005
    ..However, little information is available about the therapeutic potency of MSC transplantation in cases of dilated cardiomyopathy (DCM), an important cause of heart failure...
  5. ncbi Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis
    Noritoshi Nagaya
    Dept of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Physiol Heart Circ Physiol 287:H2670-6. 2004
    ..05 vs. control). These results suggest that intravenous administration of MSCs improves cardiac function after acute myocardial infarction through enhancement of angiogenesis and myogenesis in the ischemic myocardium...
  6. ncbi Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Circulation 110:3674-9. 2004
    ..We investigated the effects of ghrelin on left ventricular (LV) function, exercise capacity, and muscle wasting in patients with chronic heart failure (CHF)...
  7. ncbi Adrenomedullin enhances therapeutic potency of bone marrow transplantation for myocardial infarction in rats
    Takafumi Fujii
    Department of Cardiac Physiology, National Cardiovascular Center, Suita, Osaka, Japan
    Am J Physiol Heart Circ Physiol 288:H1444-50. 2005
    ..This beneficial effect may be mediated partly by the angiogenic property of AM itself and by its antiapoptotic effect on MNC...
  8. ncbi Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia
    Takashi Iwase
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    Circulation 111:356-62. 2005
    ..This effect may be mediated in part by the angiogenic potency of AM itself and the beneficial effects of AM on the survival, adhesion, and differentiation of transplanted MNCs...
  9. ncbi Infusion of adrenomedullin improves acute myocarditis via attenuation of myocardial inflammation and edema
    Bobby Yanagawa
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan
    Cardiovasc Res 76:110-8. 2007
    ..Our aim was to assess whether adrenomedullin (AM), a potent vasodilator peptide with a variety of cardioprotective effects, has a therapeutic potential for the treatment of acute myocarditis in a rat model...
  10. ncbi A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension
    Masaharu Kataoka
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Respir Crit Care Med 172:1575-80. 2005
    ..The balance between prostacyclin and thromboxane plays an important role in the regulation of pulmonary vascular tone. Recently, we developed ONO-1301, a novel, long-acting prostacyclin agonist with thromboxane synthase inhibitory activity...
  11. ncbi CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis
    Hiroaki Obata
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishiro dai, Suita, Osaka 565 8565, Japan
    Biochem Biophys Res Commun 356:60-6. 2007
    ..In conclusion, CNP infusion attenuated cardiac function in acute myocarditis through anti-inflammatory and angiogenic effects...
  12. ncbi Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia
    Takashi Iwase
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    Cardiovasc Res 66:543-51. 2005
    ..Thus, MSC transplantation may be a new therapeutic strategy for the treatment of severe peripheral vascular disease...
  13. ncbi C-type natriuretic peptide ameliorates monocrotaline-induced pulmonary hypertension in rats
    Takefumi Itoh
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    Am J Respir Crit Care Med 170:1204-11. 2004
    ..These beneficial effects may be mediated by regeneration of pulmonary endothelium, inhibition of endothelial cell apoptosis, and prevention of monocyte/macrophage infiltration and fibrinolysis impairment...
  14. ncbi Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction
    Yoshinori Miyahara
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    Nat Med 12:459-65. 2006
    ..Thus, transplantation of monolayered mesenchymal stem cells may be a new therapeutic strategy for cardiac tissue regeneration...
  15. ncbi Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats
    Hiroaki Obata
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Respir Crit Care Med 177:195-201. 2008
    ..Therefore, we developed a new drug delivery system for prostacyclin. We prepared ONO-1301MS, a novel sustained-release prostacyclin analog polymerized with poly(d,l-lactic-co-glycolic acid) (PLGA) microspheres...
  16. ncbi Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats
    Noritoshi Nagaya
    Dept of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Physiol Heart Circ Physiol 285:H2125-31. 2003
    ..10% 6-wk survival, log-rank test, P < 0.01). In conclusion, repeated inhalation of AM inhibited MCT-induced pulmonary hypertension without systemic hypotension and thereby improved survival in MCT rats...
  17. ncbi Transplantation of mesenchymal stem cells improves atrioventricular conduction in a rat model of complete atrioventricular block
    Milki Yokokawa
    Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
    Cell Transplant 17:1145-55. 2008
    ..In addition, local injection of MSC conditioned medium recovered AV conduction in 2 of 15 rats (13%). MSC transplantation improved AV conduction in a rat model of complete AVB, at least in part through antifibrotic paracrine effects...
  18. ncbi Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Circulation 109:351-6. 2004
    ..Accordingly, we investigated the effects of AM inhalation on pulmonary hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension...
  19. ncbi Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction
    Satoshi Yasuda
    Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishiro dai, Suita, Osaka 565 8565, Japan
    Clin Sci (Lond) 112:43-9. 2007
    ..A pleiotropic effect of statins appears to be associated with the modulation of cardiac MMP activation, which may be potentially beneficial in the attenuation of post-infarction LV remodelling...
  20. ncbi A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats
    Takefumi Itoh
    Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
    Am J Respir Crit Care Med 169:34-8. 2004
    ..These results suggest that combination therapy with oral sildenafil and beraprost attenuates the development of MCT-induced pulmonary hypertension compared with treatment with each drug alone...
  21. ncbi Sex hormone and gender difference--role of testosterone on male predominance in Brugada syndrome
    Wataru Shimizu
    Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
    J Cardiovasc Electrophysiol 18:415-21. 2007
    ..Brugada syndrome has been reported to be thinner than asymptomatic normal controls. We tested the hypothesis that higher testosterone level associated with lower visceral fat may relate to Brugada phenotype and male predominance...
  22. ncbi Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice
    Shinsuke Murakami
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan
    Am J Physiol Lung Cell Mol Physiol 290:L59-65. 2006
    ....
  23. ncbi Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia
    Shin Ishikane
    Department of Perinatology, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    Stem Cells 26:2625-33. 2008
    ..Thus, allogeneic injection of FM-MSC may be a new therapeutic strategy for the treatment of severe peripheral vascular disease. Disclosure of potential conflicts of interest is found at the end of this article...
  24. ncbi Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats
    Kenichiro Hanabusa
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    Stroke 36:853-8. 2005
    ..CONCLUSIONS: AM enhanced the therapeutic potency of MSCs, including neurological improvement, possibly through inhibition of MSC apoptosis and induction of angiogenesis...
  25. ncbi Beraprost sodium enhances neovascularization in ischemic myocardium by mobilizing bone marrow cells in rats
    Yoshinori Miyahara
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan
    Biochem Biophys Res Commun 349:1242-9. 2006
    ..These results suggest that beraprost has beneficial effects on ischemic myocardium partly by its ability to enhance neovascularization in ischemic myocardium by mobilizing bone marrow cells...
  26. ncbi Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans
    Mitsunobu Enomoto
    Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
    Clin Sci (Lond) 105:431-5. 2003
    ..In conclusion, subcutaneous administration of ghrelin dose-dependently induced relatively specific GH release and enhanced cardiac performance in humans...
  27. ncbi Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome
    Wataru Shimizu
    Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Japan
    Heart Rhythm 1:276-83. 2004
    ..The aim of this study was to test the hypothesis that epinephrine test may have diagnostic value for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome (LQTS)...
  28. ncbi Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
    Chest 123:338-43. 2003
    ....
  29. ncbi Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction
    Fumiaki Ono
    Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
    Chest 123:1583-8. 2003
    ..CONCLUSIONS: This preliminary study suggests that oral administration of BPS may improve hemodynamics and survival in patients with peripheral-vessel CTEPH, for which there is no surgical option...
  30. ncbi Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension
    Takefumi Itoh
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan
    Respirology 11:158-63. 2006
    ..Taking into account the chemoattractant activity of MCP-1, these results imply a contribution of MCP-1 to the development of pulmonary hypertension...
  31. ncbi Adrenomedullin regenerates alveoli and vasculature in elastase-induced pulmonary emphysema in mice
    Shinsuke Murakami
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan
    Am J Respir Crit Care Med 172:581-9. 2005
    ..CONCLUSIONS: Adrenomedullin improved elastase-induced emphysema at least in part through mobilization of bone marrow cells and the direct protective effects on alveolar epithelial cells and endothelial cells...
  32. ncbi Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis
    Shunsuke Ohnishi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Fujishirodai 5 7 1, Osaka 565 8565, Japan
    J Mol Cell Cardiol 42:88-97. 2007
    ..MSC transplantation attenuated myocardial injury and dysfunction in a rat model of acute myocarditis, at least in part through paracrine effects of MSC...
  33. ncbi Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: benefits of a novel nonviral vector, gelatin
    Noriyuki Tokunaga
    Department of Cardiac Physiology, National Cardiovascular Center Research Institute, Osaka, Japan
    Circulation 109:526-31. 2004
    ..Thus, gelatin-mediated AM gene transfer may be a new therapeutic strategy for the treatment of peripheral vascular diseases...
  34. ncbi Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease
    Takefumi Itoh
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Am J Respir Crit Care Med 170:879-82. 2004
    ..In conclusion, plasma ghrelin was elevated in underweight patients with chronic obstructive pulmonary disease, and the level was associated with a cachectic state and abnormality of pulmonary function...
  35. ncbi Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells
    Chiaki Nakanishi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Biochem Biophys Res Commun 374:11-6. 2008
    ..In conclusion, MSC-derived conditioned medium had protective effects on CPC and enhanced their migration and differentiation...
  36. ncbi Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway
    Hiroyuki Okumura
    Department of Biochemistry, National Cardiovascular Center Research Institute, Osaka, Japan
    Circulation 109:242-8. 2004
    ..CONCLUSIONS: Short-term infusion of AM significantly attenuated myocardial ischemia/reperfusion injury. These cardioprotective effects are attributed mainly to antiapoptotic effects of AM via a PI3K/Akt-dependent pathway...
  37. ncbi Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles
    Kentaro Otani
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    J Control Release 133:146-53. 2009
    ..Our results indicate that US-MB could serve as a nonviral delivery method of siRNA into MSC. The transplantation of genetically modified MSC by US-MB could be a useful strategy for regenerative medicine in the future...
  38. ncbi Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions
    Shunsuke Ohnishi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Osaka 565 8565, Japan
    FEBS Lett 581:3961-6. 2007
    ..MSC may exert paracrine anti-fibrotic effects at least in part through regulation of CFB proliferation and collagen synthesis...
  39. ncbi Sustained upregulation of inflammatory chemokine and its receptor in aneurysmal and occlusive atherosclerotic disease: results form tissue analysis with cDNA macroarray and real-time reverse transcriptional polymerase chain reaction methods
    Masakazu Yamagishi
    Division of Cardiovascular Medicine and Bioscience, National Cardiovascular Center and Research Institute, Suita, Japan
    Circ J 69:1490-5. 2005
    ....
  40. ncbi Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
    Circulation 108:889-95. 2003
    ..We investigated whether transplantation of vasodilator gene-transduced EPCs ameliorates monocrotaline (MCT)-induced pulmonary hypertension in rats...
  41. ncbi Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension
    Fumio Sakamaki
    Division of Cardiology and Pulmonary Circulation, Department of Medicine, National Cardiovascular Center, Osaka, Japan
    Chest 124:1305-11. 2003
    ....
  42. ncbi Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension
    Fumiaki Ono
    Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
    Circ J 67:375-8. 2003
    ..Thus, oral administration of BPS may be a new therapeutic strategy for the treatment of secondary precapillary PH...
  43. ncbi Pulmonary vasodilator response to adrenomedullin in patients with pulmonary hypertension
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita 565 8565, Japan
    Hypertens Res 26:S141-6. 2003
    ..These results suggest that, on a molar basis, AM may have much more potent pulmonary vasodilator activity than ACh and ATP, and thus may have beneficial hemodynamic effects in patients with pulmonary hypertension...
  44. ncbi Contrast sonography enables noninvasive and quantitative assessment of neovascularization after stem cell transplantation
    Kentaro Otani
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Japan
    Ultrasound Med Biol 34:1893-900. 2008
    ..01; vs. capillary density: r = 0.52, p < 0.05). The results of our study imply that the contrast sonography-derived beta-ratio is a useful parameter that reflects the perfusion after cell transplantation in ischemic hindlimb...
  45. ncbi Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema
    Donghao Jin
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Cardiovasc Res 80:339-45. 2008
    ..Lymphoedema is a common but refractory disorder that is difficult to be treated with conventional therapy. We therefore investigated whether AM promotes lymphangiogenesis and improves lymphoedema...
  46. ncbi Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method
    Takeo Higashikata
    Division of Cardiovascular Medicine and Bioscience, National Cardiovascular Center and Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan
    Atherosclerosis 185:165-72. 2006
    ....
  47. ncbi Sustained-release adrenomedullin ointment accelerates wound healing of pressure ulcers
    Kazuhiko Harada
    Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan
    Regul Pept 168:21-6. 2011
    ..Therefore, sustained-release AM ointment may be a novel therapeutic agent for pressure ulcers...
  48. ncbi Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy
    Michiko Ishida
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center, Osaka, Japan
    J Heart Lung Transplant 23:436-45. 2004
    ..In addition, electron microscopy showed that myocardium in the TX group was most maintained. CONCLUSION: Bone marrow mononuclear cell transplantation had beneficial effects in doxorubicin-induced cardiomyopathy...
  49. ncbi Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans
    Koji Miyamoto
    Department of Medicine, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan
    Circulation 114:2679-84. 2006
    ..Given the current incomplete knowledge of the safety and efficacy of this strategy, careful long-term monitoring is required for future patients receiving this treatment...
  50. ncbi Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells
    Shunsuke Ohnishi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center, 5 7 1 Fujishirodai, Osaka 565 8565, Japan
    Stem Cells 25:1166-77. 2007
    ..Our results may provide information on the differential molecular mechanisms regulating the properties of MSC and MNC under ischemic conditions. Disclosure of potential conflicts of interest is found at the end of this article...
  51. ncbi Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats
    Takefumi Itoh
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka 565 8565, Japan
    Am J Physiol Lung Cell Mol Physiol 293:L446-52. 2007
    ..This beneficial effect of AM on acute lung injury may be mediated by inhibition of inflammation, hyperpermeability, and alveolar wall cell apoptosis...
  52. ncbi Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial
    Keisuke Miki
    Department of Internal Medicine, National Hospital Organization Toneyama National Hospital, Toyonaka, Japan
    PLoS ONE 7:e35708. 2012
    ..Ghrelin is a novel growth hormone (GH)-releasing peptide with GH-independent effects. The efficacy and safety of adding ghrelin to pulmonary rehabilitation (PR) in cachectic COPD patients were investigated...
  53. ncbi Tissue regeneration as next-generation therapy for COPD--potential applications
    Shunsuke Ohnishi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
    Int J Chron Obstruct Pulmon Dis 3:509-14. 2008
    ....
  54. ncbi Mesenchymal stem cells for the treatment of heart failure
    Shunsuke Ohnishi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan
    Int J Hematol 86:17-21. 2007
    ..On the basis of information obtained from basic and translational research, several clinical trials have recently been started to evaluate the safety and efficacy of autologous MSC for heart failure...
  55. ncbi [Regenerative medicine for heart failure]
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute
    Nihon Rinsho 66:978-83. 2008
    ..On the basis of information obtained from basic and translational research, several clinical trials have recently been started to evaluate the safety and efficacy of autologous MSC for heart failure...
  56. ncbi Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples
    Hiroshi Hosoda
    Department of Biochemistry, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan
    Clin Chem 50:1077-80. 2004
  57. ncbi [Adrenomedullin in pulmonary hypertension]
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute
    Nippon Rinsho 62:264-8. 2004
  58. ncbi [Ghrelin and cardiovascular disease]
    Yoshito Shimizu
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute
    Nippon Rinsho 62:396-8. 2004
  59. ncbi Adrenomedullin infusion during ischemia/reperfusion attenuates left ventricular remodeling and myocardial fibrosis in rats
    Hiroyuki Okumura
    Department of Biochemistry, National Cardiovascular Center Research Institute, Suita, Japan
    Hypertens Res 26:S99-104. 2003
    ..Based on these results, the cardioprotective effects of AM may be attributed at least partly to its anti-apoptotic effect...
  60. ncbi [Ghrelin]
    Shunsuke Ohnishi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute
    Nippon Rinsho 64:151-5. 2006
  61. ncbi Adrenomedullin in the treatment of pulmonary hypertension
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujisjirodai, Suita, Osaka 565 8565, Japan
    Peptides 25:2013-8. 2004
    ..These results suggest that additional administration of AM may be effective in patients with pulmonary hypertension. AM may be a promising endogenous peptide for the treatment of pulmonary hypertension...
  62. ncbi Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka
    Intern Med 45:127-34. 2006
    ..These results suggest that ghrelin has anti-cachectic effects through GH-dependent and independent mechanisms. Thus, administration of ghrelin may be a new therapeutic strategy for the treatment of cardiopulmonary-associated cachexia...
  63. ncbi Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease
    Hiroyuki Okumura
    Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
    Chest 122:1096-8. 2002
    ..These results suggest that continuous IV PGI(2) therapy may serve as a bridge to transplantation in some cases of PVOD...
  64. ncbi Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
    Ann Thorac Surg 74:180-4; discussion 184. 2002
    ..However, whether plasma BNP may serve as a marker for the efficacy of pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension remains unknown...
  65. ncbi Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
    J Cardiovasc Pharmacol 39:754-60. 2002
    ..Unlike ANP, IV administration of adrenomedullin enhanced left ventricular myocardial contraction and improved left ventricular relaxation without increasing myocardial oxygen consumption in patients who had had a myocardial infarction...
  66. ncbi Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome
    Wataru Shimizu
    Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishiro dai, Suita, Osaka 565 8565, Japan
    J Am Coll Cardiol 41:633-42. 2003
    ..This study was designed to test the hypothesis that epinephrine infusion may be a provocative test able to unmask nonpenetrant KCNQ1 mutation carriers...
  67. ncbi Stem cell implantation for myocardial disorders
    Kenichi Yamahara
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Curr Drug Deliv 5:224-9. 2008
    ....
  68. ncbi Higher prevalence of obstructive airway disease in patients with thoracic or abdominal aortic aneurysm
    Fumio Sakamaki
    Division of Cardiology and Pulmonary Circulation, Department of Medicine, National Cardiovascular Center, Suita Shi, Osaka, Japan
    J Vasc Surg 36:35-40. 2002
    ..This study was performed to determine whether patients with AA have a higher than average prevalence of obstructive airway disease...
  69. ncbi Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome
    Wataru Shimizu
    Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
    J Am Coll Cardiol 39:1984-91. 2002
    ..This study compared the effects of beta-blockade on transmural and spatial dispersion of repolarization (TDR and SDR, respectively) between the LQT1 and LQT2 forms of congenital long QT syndrome (LQTS)...
  70. ncbi Postexercise VO2 "Hump" phenomenon as an indicator for inducible myocardial ischemia in patients with acute anterior myocardial infarction
    Hiroshi Takaki
    Department of Cardiovascular Dynamics, National Cardiovascular Center Research Institute, 5 7 1 Fujishiro dai, Osaka, 565 8565, Japan
    Int J Cardiol 111:67-74. 2006
    ..We examined this hypothesis in patients with anterior q-wave myocardial infarction in whom the accuracy to identify ischemia by exercise ECG is limited...
  71. ncbi Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension
    Kazuki Fukuchi
    Department of Radiology, National Cardiovascular Center, Suita, Osaka, Japan
    J Nucl Med 43:757-61. 2002
    ..The aim of this study was to evaluate quantitatively the heterogeneity of lung perfusion scans in patients with primary pulmonary hypertension (PPH) and to compare it with the severity of disease...
  72. ncbi [Ghrelin in the treatment of cardiovascular disease]
    Noritoshi Nagaya
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute
    Nippon Rinsho 62:430-4. 2004
  73. ncbi [Combined therapy with adrenomedullin and cell transplantation]
    Takashi Iwase
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute
    Nippon Rinsho 62:296-301. 2004
  74. ncbi Drug therapy of primary pulmonary hypertension
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
    Am J Cardiovasc Drugs 4:75-85. 2004
    ..These noninvasive parameters may be helpful as part of the evaluation of treatment in patients with PPH and, in particular, as a guide to the selection and timing for alternative therapies...
  75. ncbi Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists
    Masakazu Yamagishi
    Division of Cardiovascular Medicine, National Cardiovascular Center, Suita, Japan
    Circ J 67:1029-35. 2003
    ..High LDL-C, which might alter the underlying coronary endothelial function and/or accelerate atherosclerotic lesions, could also contribute to the occurrence of cardiac events, particularly in patients without significant CAS...
  76. ncbi Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries
    Mikiyasu Shirai
    Department of Cardiac Physiology, National Cardiovascular Centre Research Institute, 5 7 1 Fujishiro dai, Suita, Osaka 565 8565, Japan
    Br J Pharmacol 139:899-910. 2003
    ..Such NOS upregulation may serve to attenuate hypoxic vasoconstriction, which occurs primarily in MPA and inhibit the progress of pulmonary hypertension...
  77. ncbi Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka 565 8565, Japan
    Regul Pept 114:71-7. 2003
    ..Thus, administration of ghrelin may be a new therapeutic strategy for the treatment of severe chronic heart failure (CHF)...
  78. ncbi Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure
    Noritoshi Nagaya
    Department of Internal Medicine, National Cardiovascular Center, 5 7 1 Fujishirodai, Suita, Osaka, 565 8565, Japan
    Curr Opin Pharmacol 3:146-51. 2003
    ..These results suggest that ghrelin has therapeutic potential in the treatment of severe chronic heart failure...
  79. ncbi Mesenchymal stem cells for the treatment of heart disease
    Kenichi Yamahara
    Regen Med 2:107-9. 2007
  80. ncbi Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction
    Yutaka Sakakibara
    Department of Cardiovascular Surgery, Kyoto University, Graduate School of Medicine, Japan
    Ann Thorac Surg 74:25-30. 2002
    ..Further investigation is warranted for optimal clinical application to the failing heart...
  81. ncbi Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: an experimental study
    Yutaka Sakakibara
    Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Circulation 106:I193-7. 2002
    ..The results suggest that repair surgery combined with fetal CM-TX may enhance the surgical benefits for patients with LV aneurysm in the long term...
  82. ncbi Myocardial velocity gradient reflects the severity of myocardial damage regardless of the presence or absence of mitral regurgitation
    Yoshito Shimizu
    Second Department of Internal Medicine, Hiroshima University School of Medicine, Hirsohima, Japan
    J Am Soc Echocardiogr 16:246-53. 2003
    ..MVG may reflect the severity of myocardial damage regardless of the presence or absence of complicating MR...
  83. ncbi Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats
    Yoshito Shimizu
    Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    Biochem Biophys Res Commun 310:830-5. 2003
    ..These results suggest that administration of ghrelin improves endothelial dysfunction and increases eNOS expression in rats through GH-independent mechanisms...
  84. ncbi Postnatal neovascularization by endothelial progenitor cells immortalized with the simian virus 40T antigen gene
    Hui-ying Qiu
    Division of Hematology and Oncology, Department of Medicine, Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan
    Int J Oncol 28:815-21. 2006
    ..The immortalized HYCEC-1 cells are suggested to be a class of EPCs that can efficiently participate in postnatal neovasculogenesis in the ischemic hind limb, and may also be a useful tool for studying tumor vessel formation...
  85. ncbi Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran
    Jun ichiro Jo
    Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
    Tissue Eng 13:313-22. 2007
    ..Thus, this genetic engineering technology using the non-viral spermine-dextran is a promising strategy to improve MSC therapy for ischemic heart disease...